CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton’s tyrosine kinase

Bruton's tyrosine kinase (BTK) regulates the B-cell receptor (BCR) signaling pathway, which, in turn, plays a critical role in B-cell chronic lymphocytic leukemia (B-CLL) pathogenesis. The BTK-specific inhibitor Ibrutinib blocks BCR signaling and is now approved as effective B-CLL therapy. Chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Montresor, Alessio, Toffali, Lara, Rigo, Antonella, Ferrarini, Isacco, Vinante, Fabrizio, Laudanna, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205546/
https://www.ncbi.nlm.nih.gov/pubmed/30416684
http://dx.doi.org/10.18632/oncotarget.26212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205546/
https://www.ncbi.nlm.nih.gov/pubmed/30416684
http://dx.doi.org/10.18632/oncotarget.26212

Ejemplares similares